HUMAN MONOCLONAL ANTIBODIES TO DENDRITIC CELLS

Application 1254/CHENP/2004 published 2006-04-28, filed 2004-06-07
Isolated human monoclonal antibodies and antigen-binding portions thereof which specifically bind to dendritic cells are disclosed. Also disclosed are bispecifics, immunotoxins and antigen conjugates which include the antibodies or antibody portions. The human antibodies can be produced in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

Applicant

CELLDEX THERAPEUTICS,
519 ROUTE 173 WEST, BLOOMSBURY,, NEW JERSEY 08804, U.S.A

Inventor

International Info

Classification: C12P 21/08, C07K 16/00, A61K 39/00, 39/385
Publication Number: PCT/US2002/036036

Priority Information

10/035,637 USA 2001-11-07